Your browser doesn't support javascript.
loading
Combined BRM270 and endostatin inhibit relapse of NSCLC while suppressing lung cancer stem cell proliferation induced by endostatin.
Gu, Yan-Hui; Shen, Yong-Chun; Ou-Yang, Yao; Rao, Xi-Min; Fu, Dan-Dan; Wen, Fu-Qiang.
Afiliación
  • Gu YH; Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China.
  • Shen YC; Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Zunyi Medical College, Zunyi, Guizhou 563000, China.
  • Ou-Yang Y; Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China.
  • Rao XM; Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Zunyi Medical College, Zunyi, Guizhou 563000, China.
  • Fu DD; Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Zunyi Medical College, Zunyi, Guizhou 563000, China.
  • Wen FQ; Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Zunyi Medical College, Zunyi, Guizhou 563000, China.
Mol Ther Oncolytics ; 22: 565-573, 2021 Sep 24.
Article en En | MEDLINE | ID: mdl-34553041

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Mol Ther Oncolytics Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Mol Ther Oncolytics Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos